Canada markets closed

180 Life Sciences Corp. (ATNF)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9900+0.4300 (+27.56%)
At close: 04:00PM EDT
2.0707 +0.08 (+4.06%)
After hours: 07:59PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-15,948
-19,935
-38,726
-20,325
-10,884
-
Depreciation & amortization
88.204
105.675
109.004
109.947
125.333
-
Deferred income taxes
-8.216
-2,350
-942.749
-24.803
-20.427
-
Stock based compensation
2,984
2,283
2,965
5,001
1,118
-
Change in working capital
-667.302
-14.104
2,723
-8,807
2,332
-
Accounts Payable
368.018
286.41
1,215
-5,731
2,227
-
Other working capital
-14,228
-10,922
-12,128
-19,371
-3,872
-
Other non-cash items
321.143
89.189
331.591
-917.424
717.666
-
Net cash provided by operating activites
-14,228
-10,922
-12,128
-19,371
-3,872
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-
-144.402
Other investing activites
-
-
-
-
11,484
-649.825
Net cash used for investing activites
-
-
-
0
14,491
-708.149
Cash flows from financing activities
Debt repayment
-1,561
-1,257
-1,672
-817.594
-72.843
-
Common stock issued
6,500
5,999
12,500
26,666
72.5
-
Common stock repurchased
-
0
-1,015
0
-9,006
-
Other financing activites
-529.982
195.953
-
-2,055
-201.859
124.369
Net cash used privided by (used for) financing activities
6,027
5,908
10,874
25,412
-8,734
-
Net change in cash
-8,099
-4,994
-1,254
6,116
2,025
-
Cash at beginning of period
11,688
6,970
8,225
2,109
83.397
-
Cash at end of period
3,486
1,976
6,970
8,225
2,109
-
Free Cash Flow
Operating Cash Flow
-14,228
-10,922
-12,128
-19,371
-3,872
-
Capital Expenditure
-
-
-
-
-
-144.402
Free Cash Flow
-14,228
-10,922
-12,128
-19,371
-3,872
-